This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
LifeSpan Biosciences
product type :
antibody
product name :
AMELX Antibody (N-Terminus) LS-C46872
catalog :
LS-C46872
clonality :
polyclonal
host :
domestic rabbit
conjugate :
nonconjugated
reactivity :
human, rat
product information
AntibodyID :
46688
AntibodyName :
LS-C46872
TargetSpecies :
Rat
Host Species :
Rabbit
Product Name :
AMELX Antibody (N-Terminus) LS-C46872
Specificity :
synthetic peptide corresponding to N-terminal residues of rat LRAP(leucine-rich amelogenin peptide precursor)
ClonalityDesc :
Polyclonal
AntibodyModification :
Unconjugated
AntigenModification :
N-Terminus
PresentationDesc :
PBS, 0.01% Sodium Azide, 50% Glycerol
ImmunogenType :
Synthetic peptide
ImmunogenDesc :
Synthetic peptide from rat AMELX.
PurificationDesc :
Immunoaffinity purified
Gene :
AMELX
StandardGeneSymbol :
AMELX
Reactivity :
Rat
Usage :
ELISA
ShortWebDescription :
AMELX antibody LS-C46872 is an unconjugated rabbit polyclonal antibody to rat AMELX (N-Terminus). Validated for ELISA.
Synonyms :
AMELX, Amelogenin, X isoform, Amelogenin, X-linked, AMG, AIH1, ALGN, Amelogenesis imperfecta 1, AMGX, AMGL, AI1E
SalesRegion :
Worldwide
company information
LifeSpan Biosciences
2401 Fourth Avenue, Suite 900
Seattle, WA 98121
CustomerSupport@lsbio.com
https://www.lsbio.com
1-206-464-1554
headquarters: USA
Since 1995, LifeSpan has been the industry leader in molecular pathology, specializing in the localization of proteins in normal and diseased tissues, both human and non-human. We offer more than 74,000 antibodies, custom designed immunohistochemistry (IHC) studies, immediately available human tissue IHC profiles for more than 500 proteins, and histology and pathology services. Our bank of 2 million specimens is available to support our customers' contract research studies and contains frozen and formalin-fixed (FFPE) normal and diseased tissues. Our contract services are comprehensive; they include study design, antibody sourcing and characterization, tissue sourcing and validation, immunolabeling, trouble shooting, and interpretation of the results by a LifeSpan pathologist.